Led by specialist consultant Nathan Sharpe, Diagnostics Digest invites thought leaders to discuss industry insights and the latest news and trends in the diagnostics space.
Nathan works across Point-of-Care Diagnostics on a global scale. He is fascinated by the way in which Point of Care testing is vitally affecting our everyday lives and is always looking to connect with innovative individuals and organisations working in this area. Nathan provides recruitment services for both commercial and non-commercial roles.
CM Life Science is a solution focussed executive search firm. That's why our specialist consultants work with our clients and candidates to provide a bespoke recruitment service that mirrors their individual objectives.
Hosted on Acast. See acast.com/privacy for more information.
Led by specialist consultant Nathan Sharpe, Diagnostics Digest invites thought leaders to discuss industry insights and the latest news and trends in the diagnostics space.
Nathan works across Point-of-Care Diagnostics on a global scale. He is fascinated by the way in which Point of Care testing is vitally affecting our everyday lives and is always looking to connect with innovative individuals and organisations working in this area. Nathan provides recruitment services for both commercial and non-commercial roles.
CM Life Science is a solution focussed executive search firm. That's why our specialist consultants work with our clients and candidates to provide a bespoke recruitment service that mirrors their individual objectives.
Hosted on Acast. See acast.com/privacy for more information.
In this episode of Diagnostics Digest, Adam speaks to Dennis Merkle, CEO of Europe and Global Head of Biopharma Business for molecular insights company, Predicine.
Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Here we jump into a well-rounded discussion on the benefits of liquid biopsy in today's oncology market.
This conversation comes in three parts. In part two, we delve into critical barriers within the market and how to overcome these. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available.
If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at adam.hargeaves@lifesci-cm.com.
Hosted on Acast. See acast.com/privacy for more information.
